• Home
  • About
  • The MDT
  • Science & innovation
    • New Therapies
    • Learning
    • Research & Clinical Trials
  • News & features
    • Features
    • News & Updates
  • Publications
    • General Publications
    • Clinical Guidelines
    • Patient Guidelines
  • Events
  • Contact
National Haemoglobinopathy Panel | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK
National Haemoglobinopathy Panel | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK

National Haemoglobinopathy Panel | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK | NHP Haemoglobinopathy England | Sickle Cell Thalassaemia | Rare Inherited Anaemia UK

  • X
  • LinkedIn
  • Instagram
  • Home
  • About
  • The MDT
  • Science & innovation
    • New Therapies
    • Learning
    • Research & Clinical Trials
  • News & features
    • Features
    • News & Updates
  • Publications
    • General Publications
    • Clinical Guidelines
    • Patient Guidelines
  • Events
  • Contact

Clinical Guidelines

Clinical Guidelines

20250831 RCPath National Examiner's Good Practice in Sickle Cell Disease

Posted 31st August 2025

Posted 3 days ago

By NHP Office

Clinical Guidelines Features News & Updates Publications

20250831 RCPath National Examiner's Good Practice in Sickle Cell Disease

The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.

Read More
Mortality Reporting Pathway

Posted 11th August 2025

Posted 3 weeks ago

By NHP Office

Clinical Guidelines Features Publications

Mortality Reporting Pathway

First iteration of the mortality reporting pathway for haemoglobinopathies.

Read More
SOP- Casgevy (Exagamglogene Autotemcel) for Transfusion-dependent Thalassaemia

Posted 9th September 2024

Posted 12 months ago

By NHS England

Clinical Guidelines New Therapies Publications

SOP- Casgevy (Exagamglogene Autotemcel) for Transfusion-dependent Thalassaemia

University College London have produced a Standard Operating Procedure (SOP) for the assessment and work up of exagamglogene autotemcel (Casgevy™) for transfusion-dependent beta-thalassaemia

Read More

Quick links

Home
About
The MDT
Science & innovation
News & features
Events
Contact

Get in touch

The National Haemoglobinopathy Panel
Women’s and Children’s Academic Health - Kings College London
Becket House
1 Lambeth Palace Rd
London, SE1 7EU

Connect

  • X
  • LinkedIn
  • Instagram

  • NHP Haemoglobinopathy England
  • Sickle Cell Thalassaemia
  • Rare Inherited Anaemia UK

Website Design by Webfactory